Detalles de la búsqueda
1.
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma.
Cancer
; 129(14): 2179-2191, 2023 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37021929
2.
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis.
Blood
; 137(23): 3291-3305, 2021 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33657221
3.
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
Haematologica
; 108(1): 150-160, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35443559
4.
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
Haematologica
; 108(7): 1900-1908, 2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779595
5.
Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia.
Am J Hematol
; 98(4): 608-619, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36606713
6.
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study.
Am J Hematol
; 98(2): 300-308, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36588409
7.
Scedosporium infection disseminated "from toe to head" in allogeneic stem cell transplant recipient: a case report.
BMC Infect Dis
; 23(1): 353, 2023 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37231339
8.
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
Biol Blood Marrow Transplant
; 26(6): 1137-1143, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32062061
9.
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 26(11): 2139-2146, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32781289
10.
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Cancer
; 126(2): 293-303, 2020 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31568564
11.
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation.
Cancer
; 126(10): 2279-2287, 2020 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32049359
12.
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy.
Br J Haematol
; 191(1): 44-51, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32430944
13.
Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma.
Br J Haematol
; 190(4): 573-582, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32314807
14.
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy.
Oncologist
; 25(10): 878-885, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32720734
15.
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma.
Oncologist
; 25(6): e993-e997, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32275786
16.
Biosimilar infliximab administration for the management of acute graft-versus-host disease.
J Oncol Pharm Pract
; 26(8): 2047-2051, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32356680
17.
Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(2): e46-e54, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30481594
18.
Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(5): e145-e154, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30521975
19.
Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Gray Zone Lymphoma: A US Multicenter Collaborative Study.
Biol Blood Marrow Transplant
; 24(3): 486-493, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29225164
20.
Impact of cachexia on outcomes in aggressive lymphomas.
Ann Hematol
; 96(6): 951-956, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28417157